ScoreWhy is Vaxart, Inc. ?
1
The company has declared positive results for the last 8 consecutive quarters
- NET SALES(HY) At USD 143.47 MM has Grown at 297.84%
- OPERATING CASH FLOW(Y) Highest at USD 15.27 MM
- NET PROFIT(HY) Higher at USD 60.22 MM
2
With ROE of 18.60%, it has a very attractive valuation with a 1.78 Price to Book Value
- Over the past year, while the stock has generated a return of 97.88%, its profits have risen by 124.4% ; the PEG ratio of the company is 0.1
3
High Institutional Holdings at 20.86%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 97.88% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Vaxart, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Vaxart, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Vaxart, Inc.
97.88%
-0.10
110.39%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
125.71%
EBIT Growth (5y)
20.90%
EBIT to Interest (avg)
-47.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
1.09
Tax Ratio
0.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.86%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.78
EV to EBIT
5.51
EV to EBITDA
3.91
EV to Capital Employed
3.21
EV to Sales
0.42
PEG Ratio
0.08
Dividend Yield
NA
ROCE (Latest)
58.25%
ROE (Latest)
18.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend28What is working for the Company
NET SALES(HY)
At USD 143.47 MM has Grown at 297.84%
OPERATING CASH FLOW(Y)
Highest at USD 15.27 MM
NET PROFIT(HY)
Higher at USD 60.22 MM
ROCE(HY)
Highest at 53.1%
RAW MATERIAL COST(Y)
Fallen by -2.56% (YoY
-3What is not working for the Company
NET SALES(Q)
At USD 39.23 MM has Fallen at -33.87%
Here's what is working for Vaxart, Inc.
Net Profit
At USD 60.22 MM has Grown at 318.39%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 15.27 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD 60.22 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -2.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Vaxart, Inc.
Net Sales
At USD 39.23 MM has Fallen at -33.87%
over average net sales of the previous four periods of USD 59.31 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
